Show simple item record

dc.contributor.authorChurch, D.
dc.contributor.authorHay, J.
dc.contributor.authorSansom, O. J.
dc.contributor.authorMaka, N.
dc.contributor.authorOien, K. A.
dc.contributor.authorIveson, T. J.
dc.contributor.authorSaunders, Mark P
dc.contributor.authorEdwards, J.
dc.contributor.authorHarkin, A.
dc.contributor.authorBoukovinas, I.
dc.contributor.authorMoustou, E.
dc.contributor.authorMessaritakis, I.
dc.contributor.authorChondrozoumaki, M.
dc.contributor.authorGeorgoulias, V.
dc.contributor.authorBoquet, I.
dc.contributor.authorPages, F.
dc.contributor.authorCatteau, A.
dc.contributor.authorGalon, J.
dc.contributor.authorKelly, C.
dc.contributor.authorSouglakos, I.
dc.date.accessioned2023-01-24T10:32:20Z
dc.date.available2023-01-24T10:32:20Z
dc.date.issued2022en
dc.identifier.citationChurch D, Hay J, Sansom OJ, Maka N, Oien KA, Iveson TJ, et al. Prognostic and predictive value of Immunoscore in stage III colorectal cancer in the combined SCOT and IDEA-HORG studies. Annals of Oncology. 2022 Sep;33(7):S690-S1. PubMed PMID: WOS:000866211600330.en
dc.identifier.doi10.1016/annonc/annonc1048en
dc.identifier.urihttp://hdl.handle.net/10541/625951
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/annonc/annonc1048en
dc.titlePrognostic and predictive value of Immunoscore in stage III colorectal cancer in the combined SCOT and IDEA-HORG studiesen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentOncology Department, Wellcome Trust Centre for Human Genetics, OX3 7BN - Oxforden
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record